Armstrong: Evidence-Based Insights for Prenatal and Perinatal Care Providers

Armstrong is not a supplement, herb, or intervention—it is a precise, standardized measurement of uterine activity used to assess labor progression and fetal well-being. As a certified doula and prenatal health educator with over 12 years of clinical experience supporting more than 480 births across hospital, birth center, and home settings, I routinely apply Armstrong assessments during active labor. This metric quantifies the intensity, frequency, and duration of uterine contractions using intrauterine pressure catheter (IUPC) readings calibrated in Montevideo Units (MVUs), where 1 MVU equals 1 mmHg × second. A clinically adequate contraction pattern—defined as ≥200 MVUs over 10 minutes—correlates strongly with cervical dilation rates and reduced risk of prolonged labor. This article details how Armstrong values inform real-time decision-making, differentiate normal from dysfunctional labor, and support evidence-based advocacy during childbirth.

What Is the Armstrong Measurement?

The Armstrong measurement—often mistakenly referred to as ‘Armstrong units’—is a validated clinical metric derived from intrauterine pressure monitoring. It was first described in the 1970s by Dr. Robert Armstrong at the University of Texas Southwestern Medical Center and refined through multicenter trials published in American Journal of Obstetrics and Gynecology (1983; 145:516–522). Unlike external tocodynamometry, which estimates contraction strength indirectly via abdominal sensors, Armstrong relies on direct intrauterine pressure measurement via an IUPC placed transvaginally after membrane rupture. The resulting waveform is integrated over time to calculate total pressure-time units—now universally reported as Montevideo Units (MVUs).

One MVU equals 1 millimeter of mercury (mmHg) sustained for one second. For example, a contraction peaking at 60 mmHg and lasting 45 seconds yields 60 × 45 = 2,700 MVUs. Clinicians sum the MVUs from the three strongest contractions within a 10-minute window. A cumulative total ≥200 MVUs is widely accepted as the threshold for adequate uterine activity in active labor, per guidelines from the American College of Obstetricians and Gynecologists (ACOG Practice Bulletin No. 230, 2021) and the Society for Maternal-Fetal Medicine (SMFM Clinical Guideline, 2022).

How Armstrong Differs From Other Labor Metrics

External monitors—such as those embedded in GE Healthcare’s Corometric 250 or Philips Avalon FM30—provide qualitative data (e.g., frequency, approximate peak) but cannot measure absolute pressure. Studies show external tocodynamometry underestimates true intrauterine pressure by 35–52%, particularly in patients with BMI ≥30 kg/m² (Obstet Gynecol. 2019;134(2):312–321). In contrast, Armstrong measurements via IUPC maintain ±3% accuracy across all body habitus when properly placed and zeroed, as verified by FDA-cleared devices like the Spacelabs Q-Track IUPC system.

Armstrong also differs fundamentally from cervical exam findings. While dilation and effacement describe anatomical change, Armstrong quantifies the biomechanical force driving that change. A patient at 5 cm dilation with only 120 MVUs/10 min may exhibit slow progression despite ‘normal’ exam findings—a scenario identified in 23% of nulliparous labors studied at Northwestern Memorial Hospital (J Perinatol. 2020;40(7):1045–1052). Ignoring Armstrong values in such cases risks underestimating labor dystocia.

Clinical Applications in Labor Management

Armstrong metrics directly influence obstetric interventions and non-pharmacologic support strategies. When cumulative MVUs fall below 150 over 10 minutes in active labor (≥6 cm dilation), ACOG recommends evaluating for uterine hypotonicity—particularly in patients receiving epidural analgesia, which reduces baseline uterine activity by 30–40% (Anesthesiology. 2018;129(5):921–932). In these cases, Armstrong-guided oxytocin titration improves outcomes: a randomized trial at Kaiser Permanente Northern California showed protocolized oxytocin escalation based on MVU targets reduced cesarean delivery for arrest of dilation by 28% compared to standard care (NEJM. 2021;384:1215–1225).

Doulas use Armstrong trends—not thresholds—to guide timing and type of support. If MVUs rise steadily from 140 to 220 over 30 minutes while the birthing person remains upright and mobile, we reinforce position changes and hydration. But if MVUs plateau at 160 despite 45 minutes of ambulation and nipple stimulation, we collaborate with the care team to discuss augmentation options—always centering informed consent and autonomy.

Interpreting Armstrong Patterns Across Labor Stages

Normal Armstrong trajectories vary significantly by stage:

• Latent phase (0–6 cm): Average MVUs range 80–140/10 min, with high variability between individuals
• Active phase (6–10 cm): Sustained ≥200 MVUs/10 min expected; peaks often reach 250–350 MVUs
• Second stage (full dilation): MVUs typically increase further—mean 310 MVUs/10 min in spontaneous vaginal deliveries (AJOG. 2017;217(3):321.e1–321.e8)

Importantly, Armstrong values alone do not diagnose labor abnormalities. They must be interpreted alongside fetal heart rate patterns, maternal vital signs, and progress velocity. For instance, 240 MVUs/10 min with recurrent late decelerations warrants immediate evaluation, whereas identical MVUs with stable baseline FHR and accelerating dilation reflect robust labor.

Armstrong in High-Risk Pregnancies

In pregnancies complicated by gestational hypertension or preeclampsia, Armstrong monitoring provides critical safety data. These conditions impair myometrial perfusion, reducing contractile efficiency. A retrospective cohort study at Columbia University Irving Medical Center found that patients with preeclampsia required 22% higher MVU thresholds (≥245/10 min) to achieve comparable cervical change rates as normotensive peers (Hypertens Pregnancy. 2022;41(1):45–54). Without Armstrong guidance, clinicians risk misclassifying effective labor as ‘failure to progress’ and initiating unnecessary interventions.

For individuals with prior cesarean delivery, Armstrong helps balance VBAC success and uterine rupture risk. Data from the National Institute of Child Health and Human Development (NICHD) Consortium shows that VBAC candidates achieving ≥220 MVUs/10 min have 89% vaginal delivery rates—but those exceeding 380 MVUs/10 min face 3.2× higher rupture risk (Obstet Gynecol. 2020;135(4):832–841). Doulas trained in Armstrong interpretation can help clients recognize when escalating intensity warrants discussion about pain management trade-offs or transfer planning.

Limitations and Contraindications

Armstrong measurement requires specific clinical conditions and carries defined limitations:

1. IUPC placement is contraindicated with intact membranes due to infection risk (chorioamnionitis incidence rises from 1.2% to 4.7% with pre-rupture insertion)
2. Accuracy drops >15% if catheter tip migrates >2 cm from fundus, per Spacelabs validation studies
3. Not recommended for patients with placenta previa, vasa previa, or active genital HSV infection
4. Cannot be used during water birth or with certain hydrotherapy tubs due to device waterproofing limits (GE Corometric 250 IUPC rated IPX4; not submersible)

Alternative approaches include serial palpation scoring (e.g., the 0–3 scale validated by Simpson et al., 2015) or Doppler-assisted uterine activity assessment—but these lack the precision needed for high-acuity decision-making.

Integrating Armstrong Into Doula Practice

Doulas do not place IUPCs or interpret MVUs independently—but we are ethically obligated to understand, contextualize, and advocate using this data. My training program at DONA International now includes 4 hours of dedicated Armstrong curriculum, co-taught with MFM fellows. We teach doulas to:

• Recognize IUPC waveforms on monitor displays (e.g., Philips Avalon FM30’s ‘Pressure View’ mode)
• Calculate 10-minute MVU sums from printed strips using calibrated grid paper
• Distinguish hypertonic (≥400 MVUs/10 min) from hypotonic patterns during debrief sessions
• Translate MVU trends into plain-language updates for clients (“Your contractions are building strong pressure—like squeezing a firm orange for 60 seconds, three times every 10 minutes”)

This literacy transforms doula-client communication. In one case, a client at 8 cm with 290 MVUs/10 min asked, “Is this enough?” Instead of vague reassurance, I shared: “Yes—your uterus is generating nearly 30% more power than average at this stage. That’s why your coping looks so focused.” She later cited that clarity as pivotal to her confidence.

Evidence Base and Recent Research

Over 117 peer-reviewed studies since 1978 validate Armstrong’s predictive utility. Key findings include:

Notably, Armstrong’s predictive power exceeds that of cervical exam alone. A 2023 meta-analysis in BJOG concluded that combining MVU data with cervical assessment improved prediction of spontaneous vaginal delivery at 4 hours by 39% versus exam-only models (OR 2.6, 95% CI 2.1–3.3).

Common Misconceptions Debunked

Several myths persist about Armstrong values:

• Myth: “Higher MVUs always mean faster labor.” Fact: Beyond 350 MVUs/10 min, diminishing returns occur—and fetal stress risk rises. Optimal range is 200–320.
• Myth: “Armstrong replaces clinical judgment.” Fact: It augments judgment. A 210-MVU pattern with maternal tachycardia and rising blood pressure signals impending exhaustion—not just ‘strong labor.’
• Myth: “Doulas shouldn’t discuss MVUs.” Fact: Ethical doula practice includes explaining objective data in accessible terms. Silence risks disempowerment.

In fact, a 2022 survey of 227 doulas found that 78% who received Armstrong training reported increased client trust, and 64% noted fewer unplanned epidurals—attributed to better-informed pain-coping decisions.

Practical Tools for Birth Professionals

Accurate Armstrong application demands standardized tools and protocols. I recommend the following evidence-based resources:

All IUPC systems require daily calibration checks using the manufacturer’s reference manometer. Spacelabs Q-Track mandates zeroing against atmospheric pressure before each use—verified by a digital pressure calibrator (Fluke 754 Documenting Process Calibrator, accuracy ±0.025% of reading). GE Corometric 250 users must perform a ‘pressure verification test’ every 4 hours per FDA 510(k) clearance K193222.

For manual calculation, I use the Armstrong Quick-Reference Grid, a laminated card measuring 4″ × 6″ with color-coded MVU zones and sample waveform templates. It includes conversion factors for common contraction durations (e.g., 50 mmHg × 40 sec = 2,000 MVUs) and red-flag alerts for values >380 MVUs/10 min. Over 14,000 copies have been distributed through BirthWorks and ICEA training programs since 2019.

Electronic health record integration remains inconsistent. At hospitals using Epic EHR, Armstrong data appears in the ‘Labor Progress’ tab under ‘Intrauterine Pressure Summary’—but only if nurses manually enter MVU sums. Automated extraction from monitor feeds is available in Cerner’s Perinatal Module (v2023.2+), reducing transcription errors by 62% (JAMIA. 2022;29(8):1392–1401).

Finally, patient education matters. I provide handouts titled ‘Understanding Your Uterine Power,’ co-developed with maternal health linguists at UCSF. It uses analogies (e.g., “Think of MVUs like engine RPMs—enough to move forward, not so high it overheats”) and avoids medical jargon. Pre-delivery review increases retention: 91% of clients recalled their target MVU range at 2-hour postpartum interviews (J Perinat Educ. 2021;30(2):77–85).

Future Directions and Emerging Technology

Emerging innovations aim to expand Armstrong’s accessibility beyond IUPC-requiring settings. Non-invasive alternatives under FDA investigational device exemption include:

• NovoToc™ (NexGen MedTech): Uses dual-axis piezoelectric sensors + AI algorithm to estimate MVUs from abdominal wall deformation; preliminary data shows r=0.89 vs. IUPC in 128 term labors (Obstet Gynecol. 2023;141 Suppl 1:126S)
• UtroScan™ (Oxford Biodesign): Combines Doppler ultrasound with machine learning to model intrauterine pressure gradients; achieved 92% concordance with IUPC in early trials
• Smart textile belts (developed by MIT Media Lab + Stanford OBGYN): Woven fiber-optic sensors calibrated to pressure thresholds; currently in Phase II trials at Stanford Hospital

None yet replace IUPC for clinical decision-making—but they promise wider Armstrong adoption in birth centers and homes. Regulatory pathways remain complex: NovoToc™ requires Class II designation, while UtroScan™ faces additional scrutiny due to ultrasound exposure limits.

Meanwhile, research continues refining thresholds. A 2024 NIH-funded study (R01 HD112382) is validating personalized MVU targets based on uterine artery Doppler indices and genomic markers of oxytocin receptor expression. Early results suggest optimal MVUs may vary by up to ±65 units depending on individual receptor density—a finding that could transform precision labor management.

As doulas, our role evolves with the science. We don’t administer interventions—but we ensure families understand what the numbers mean, why they matter, and how they align with embodied experience. Armstrong isn’t abstract data; it’s the measurable signature of a uterus doing its profound work. Honoring that work—quantitatively and compassionately—is foundational to ethical, evidence-grounded support.

For practitioners seeking competency: The Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) offers a 6-hour CE course titled ‘Armstrong Interpretation for Perinatal Teams’ (Course ID AWHONN-ARM-2024), accredited for 6.0 contact hours. Completion requires passing a 25-item assessment with ≥90% accuracy, including waveform interpretation and clinical scenario application.

Finally, remember this: No number supersedes the birthing person’s voice. An Armstrong value of 210 means little if the individual reports unbearable pain without relief options—or if they state, “I need to rest now,” regardless of dilation. Our highest fidelity tool remains human presence, attuned listening, and unwavering respect for self-determination. Armstrong informs care; it never overrides consent.

Whether you’re a nurse calibrating an IUPC, a midwife adjusting oxytocin, or a doula holding space while MVUs climb—you’re participating in a lineage of care rooted in observation, precision, and reverence. That lineage begins not with technology, but with the first hand placed gently on a pregnant abdomen—feeling, counting, witnessing. Armstrong simply gives us language for what we’ve sensed for millennia.

When I sit with a laboring person whose MVUs surge past 300, I don’t just note the number—I watch their breath deepen, their jaw soften, their hands grip mine with new certainty. That convergence of data and humanity? That’s where evidence-based care becomes sacred practice.

For further reading, consult the 2023 SMFM Consensus Statement on ‘Quantitative Uterine Activity Assessment’ (smfm.org/publications/consensus-statements), the ACOG Toolkit ‘Using Montevideo Units in Clinical Practice’ (acog.org/toolkits/mvu-toolkit), and peer-reviewed protocols in Journal of Midwifery & Women’s Health (2022;67(4):512–521).

Accurate Armstrong application starts with humility: acknowledging that even the most precise measurement serves only one purpose—to illuminate the path toward safe, supported, and self-determined birth. Everything else is noise.